Willow Biosciences Inc (WLLW) — Capital Reinvestment Ratio

Latest as of March 2019: 1.45x

Willow Biosciences Inc (WLLW) has a Capital Reinvestment Ratio of 1.45x as of March 2019, meaning it reinvests 1% of its operating cash flow (CA$10.14K) in capital expenditures (CA$14.67K). See Willow Biosciences Inc (WLLW) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.45x

Capex / Operating Cash Flow

Operating Cash Flow

CA$10.14K

CAD

Capital Expenditures

CA$14.67K

CAD

Data as of

Mar 2019

Most recent filing

Annual Capital Reinvestment Ratio for Willow Biosciences Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Willow Biosciences Inc from None to None. For live market cap and broader valuation context, see market value of Willow Biosciences Inc.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow